Skip to main content
HONZ PHARMACEUTICAL CO., LTD. logo

HONZ PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 300086 ISIN · CNE100000QM6 LEI · 300300SA7ZULJ816T861 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,012 across all filing types
Latest filing 2019-05-27 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300086

About HONZ PHARMACEUTICAL CO., LTD.

https://www.honz.com.cn

HONZ Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical products, with a specialized emphasis on pediatric healthcare. The company provides a diverse range of medications specifically formulated for children, including antipyretics, analgesics, respiratory treatments, and anti-infective agents. It utilizes advanced drug delivery systems and taste-masking technologies to enhance patient compliance and therapeutic efficacy. In addition to its pediatric portfolio, the organization produces various chemical drugs and traditional Chinese medicine preparations. The company maintains multiple production bases and research centers dedicated to advancing clinical solutions and ensuring high standards of product quality across its therapeutic categories.

Recent filings

Filing Released Lang Actions
关于修改《公司章程》公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding amendments to the company's Articles of Association (公司章程). It details specific changes to the company's bylaws related to stock repurchase, board powers, and management roles. The document is a formal public notice of these changes and references that the full amended Articles are available on a regulatory information website. The document length is 3673 characters, which is relatively short and consistent with an announcement rather than a full report. There are no financial statements, detailed financial data, or management discussion of financial results. The content focuses on governance and corporate charter amendments, which aligns with governance-related disclosures. However, since it is an announcement of changes to the Articles of Association and not a full governance report or internal rules document, and given the nature of the content and length, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2019-05-27 Chinese
关于召开2018年度股东大会通知的公告
AGM Information Classification · 100% confidence The document is a detailed announcement regarding the convening of the 2018 Annual General Meeting (AGM) of 康芝药业股份有限公司. It includes information about the meeting date, voting procedures (both onsite and online), agenda items to be discussed and voted on (such as the 2018 annual report, financial statements, profit distribution plan, and appointment of auditors), registration procedures, and proxy voting instructions. The document does not contain the actual annual report or financial statements but rather serves as a formal notice to shareholders about the AGM and the matters to be considered. The length of the document (6176 characters) and its content align with a meeting notice rather than the report itself. Therefore, it fits the category of AGM Information (AGM-R).
2019-05-27 Chinese
关于聘请公司2019年度审计机构的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the appointment of the company's audit firm for the 2019 fiscal year. It details the decision made by the board and supervisory committee to reappoint the auditing firm and the associated fees. The document does not contain any actual audit report, financial statements, or detailed audit results. It is a formal announcement about the audit engagement rather than the audit report itself. The document length is short (810 characters), and it serves as a notice of the audit firm appointment. Therefore, it fits best under Audit Report / Information (AR) as it relates to audit information but is not the full audit report or annual report. FY 2019
2019-05-27 Chinese
公司章程（2019年5月）
Governance Information Classification · 100% confidence The document is titled as the "公司章程" which translates to "Company Articles of Association" or "Company Bylaws." It contains detailed provisions about the company's organization, shareholder rights, board structure, management, financial accounting, profit distribution, auditing, and procedures for shareholder meetings. The content is focused on governance rules, shareholder meetings, board and management roles, and company operational guidelines. There is no indication of financial statements, audit opinions, earnings data, or event announcements. The document is a governance document outlining internal rules and corporate governance practices. Therefore, it fits the category of Governance Information (CGR). The document length is substantial and contains the full text of the governance rules, not just an announcement or summary.
2019-05-27 Chinese
关于拟出售公司部分闲置房产的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 康芝药业股份有限公司 regarding the proposed sale of some idle real estate assets. It details the transaction overview, asset description, purpose, impact on the company, risks, approval procedures, and opinions from the board, independent directors, and supervisory board. The document is a formal disclosure about a specific asset disposal transaction, including board resolutions and independent opinions, but it does not contain financial statements or comprehensive financial data. It is not a full financial report, earnings release, or management discussion. It is also not a regulatory certification or a report publication announcement. The content fits best with a Capital/Financing Update (CAP) as it relates to company fundraising or capital structure changes through asset disposal. The document length is under 5,000 characters, but it is a full announcement, not just a notice of report publication. Therefore, the appropriate classification is CAP with high confidence.
2019-05-27 Chinese
关于公司董事辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a company director, Mr. Hu Feihong, from his position on the board and related committees. It includes details about the resignation, the reasons for it, and the impact on the company. There is no financial data, no mention of financial results, no regulatory filings about audits or reports, and no mention of shareholder votes or capital changes. The content clearly fits the category of announcements about changes in the company's board of directors or senior management.
2019-05-24 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.